Sinomenine inhibits proliferation of SGC-7901 gastric adenocarcinoma cells via suppression of cyclooxygenase-2 expression

Lv,Yifei; Li,Changshun; Li,Shuang; Hao,Zhiming

doi:10.3892/ol.2011.305

Sinomenine inhibits proliferation of SGC-7901 gastric adenocarcinoma cells via suppression of cyclooxygenase-2 expression

Authors:
- Yifei Lv
- Changshun Li
- Shuang Li
- Zhiming Hao
View Affiliations

Affiliations: Department of Gastroenterology, The First Affiliated Hospital, College of Medicine, Xi'an Jiaotong University, Xi'an 710061, P.R. China
Published online on: May 13, 2011 https://doi.org/10.3892/ol.2011.305
Pages: 741-745

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Sinomenine (SIN) is a bioactive alkaloid extracted from the Chinese medicinal plant Sinomenium acutum. Results of studies have shown that the anti-inflammatory, immunosuppressive and anti-arthritic effects of SIN are partially attributed to the inhibition of cyclooxygenase-2 (COX-2) expression. COX-2 overexpression is associated with enhanced proliferation and angiogenesis of gastric cancer (GC). SGC-7901 cells were treated with different concentrations of SIN in order to observe its effect on the proliferation of human gastric adenocarcinoma cells and to explore the potential underlying molecular mechanism via the detection of COX-2 expression. Celecoxib was used as the positive control. Morphological alterations of the cells were observed microscopically. Cell proliferation was evaluated using MTT assay. COX-2 expression was detected using semi-quantitative RT-PCR and Western blotting. The results showed that SIN inhibited the proliferation of SGC-7901 cells in a time- and dose-dependent manner. In the presence of SIN or celecoxib, SGC-7901 cells became round and detached morphologically, indicating cell apoptosis. The expression of COX-2 was inhibi-ted by SIN in a dose-dependent manner at both the mRNA and protein levels. Our findings indicate that the protective effects of SIN are mediated through the inhibition of COX-2 expression. These findings suggest a novel therapy to treat inflammation-mediated gastric adenocarcinomata.

View Figures

View References

1	Ke XY, Yu MX and Jiang M: Clinical observation on treatment of rheumatoid arthritis with sinomenine. Bei Jing Yi Xue. 8:186–188. 1986.
2	Satoh H: Electropharmacology of sinomeni caulis et rhizome and its constituents in cardiomyocytes. Am J Chin Med. 33:967–979. 2005. View Article : Google Scholar : PubMed/NCBI
3	Vieregge B, Resch K and Kaever V: Synergistic effects of the alkaloid sinomenine in combination with the immunosuppressive drugs tacrolimus and mycophenolic acid. Planta Medica. 65:80–82. 1999. View Article : Google Scholar : PubMed/NCBI
4	Dai YB, Huang X and Luo ZG: Immunosuppressive effect of sinomenine on ICAM-1 expression in rat renal allograft rejection. Mod J Integr Trad Chin West Med. 12:1358–1363. 2003.
5	Chen W, Shen YD and Zhao GS: Inhibitory effect of sinomenine on expression of cyclooxygenase-2 in lipopolysaccharide-induced PC-12 cells. China J Chin Mat Medica. 29:900–903. 2004.PubMed/NCBI
6	Zhang Y, Wu M and Li XG: Experimental study on the effect of selective COX-2 inhibitor sinomenine on HeLa cells. Prog Mod Biomed. 6:38–40. 2006.
7	Hla T, Bishop-Bailey D, Liu CH, Schaefers HJ and Trifan OC: Cyclooxygenase-1 and -2 isoenzymes. Int J Biochem Cell Biol. 31:551–557. 1999. View Article : Google Scholar
8	Morita I: Distinct functions of COX-1 and COX-2. Prostaglandins Other Lipid Mediat. 68:165–175. 2002. View Article : Google Scholar
9	Su JL, Shih JY, Yen ML, Jeng YM, Chang CC and Hsieh CY: Cyclooxygenase-2 induces EP1-and HER-2/Neu-dependent vascular endothelialgrowth factor-C up-regulation: a novel mechanism of lymphangiogenesis in lung adenocarcinoma. Cancer Res. 64:554–564. 2004. View Article : Google Scholar : PubMed/NCBI
10	Soumaoro LT, Uetake H, Higuchi T, Takagi Y, Enomoto M and Sugihara K: Cyclooxygenase-2 expression: a significant prognostic indicator for patients with colorectal cancer. Clin Cancer Res. 10:8465–8471. 2004. View Article : Google Scholar : PubMed/NCBI
11	Tucker ON, Danneberg AJ and Tang EK: Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer. Cancer Res. 59:987–990. 1999.PubMed/NCBI
12	Timoshenko AV, Chakraborty C, Wagner GF and Lala PK: COX-2-mediated stimulation of the lymphangiogenic factor VEGF-C in human breast cancer. Br J Cancer. 94:1154–1163. 2006. View Article : Google Scholar : PubMed/NCBI
13	Meric JB, Rottey S, Olaussen K, Soria JC, Khayat D and Rixe O: Cyclooxygenase-2 as a target for anticancer drug development. Crit Rev Oncol Hematol. 59:51–64. 2006. View Article : Google Scholar : PubMed/NCBI
14	Dannenberg AJ and Subbaramaiah K: Targeting cyclooxygenase-2 in human neoplasia: rationale and promise. Cancer Cell. 4:431–436. 2003. View Article : Google Scholar : PubMed/NCBI
15	Jemal A, Siegel R, Ward E, Hao Y, Xu J and Thun MJ: Cancer statistics. CA Cancer J Clin. 59:225–249. 2009.
16	Wagner AD, Grothe W, Haerting J, et al: Combination chemotherapies in advanced gastric cancer: an updated systematic review and meta-analysis. American Society of Clinical Oncology. 25:45552007.
17	Chen CN, Sung CT, Lin MT, Lee PH and Chang KJ: Clinicopathologic association of cyclooxygenase-1 and cyclooxygenase-2 expression in gastric adenocarcinoma. Ann Surg. 233:183–188. 2001. View Article : Google Scholar : PubMed/NCBI
18	Yamaca D, Ayyildiz T, Coskun U, et al: Cyclooxygenase-2 expression and its association with angiogenesis, Helicobacter pylori, and clinicopathologic characteristics of gastric carcinoma. Pathol Res Pract. 204:527–536. 2008. View Article : Google Scholar
19	Tatsuguchi A, Matsui K and Shinji Y: Cyclooxygenase-2 expression correlates with angiogenesis and apoptosis in gastric cancer tissue. Hum Pathol. 35:488–495. 2004. View Article : Google Scholar : PubMed/NCBI
20	Sun WH, Yu Q, Shen H, et al: Roles of Helicobacter pylori infection and cyclooxygenase-2 expression in gastric carcinogenesis. World J Gastroenterol. 10:2809–2813. 2004.PubMed/NCBI
21	Wang BH, Qian W and Gao YJ: Effects of inhibition of cyclooxygenase-2 by RNA interference on proliferation and apoptosis of human gastric cancer cells: an experimental study with human gastric cancer cells and mice. Nat Med J China. 86:266–271. 2006.
22	Tjiu JW, Liao YH, Lin SJ, et al: Cyclooxygenase-2 over-expression in human basal cell carcinoma cell line increases antiapoptosis, angiogenesis, and tumorigenesis. J Invest Dermatol. 126:1143–1151. 2006. View Article : Google Scholar : PubMed/NCBI
23	Fosien E: Biochemistry of cyclooxygenase (COX-2) inhibitors and molecular pathology of COX-2 in neoplasia. Crit Rev Las Sci. 37:431–502. 2000. View Article : Google Scholar : PubMed/NCBI
24	Willams CS and DuBois RN: Prostaglandin endoperoxide synthase: why two isoforms? Am J Physiol. 270:393–400. 1996.PubMed/NCBI
25	Konturek PC, Hartwich A, Zuchowicz M, et al: Helicobacter pylori gastrin and cyclooxygenases in gastric cancer. J Physiol Pharmacol. 51:737–749. 2000.
26	Yu J, Leung WK, Chen J, Ebert MPA, Malfertheiner P and Sung JJY: Expression of peroxisome proliferators-activated receptor δ in human gastric cancer and its response to specific COX-2 inhibitor. Cancer Lett. 223:11–17. 2005.
27	Da MX, Wu XT, Wang J, et al: Expression of cyclooxygenase-2 and vascular endothelial growth factor-c correlates with lymph-angiogenesis and lymphatic invasion in human gastric cancer. Arch Med Res. 39:92–99. 2008. View Article : Google Scholar : PubMed/NCBI
28	Tegeder I, Pfeilschifter J and Geisslinger G: Cyclooxygenase-independent actions of cyclooxygenase inhibitors. FASEB J. 15:2057–2072. 2001. View Article : Google Scholar : PubMed/NCBI
29	Yuan XL, Chen L, Li MX, et al: Elevated expression of Foxp3 in tumor-infiltrating Treg cells suppresses T-cell proliferation and contributes to gastric cancer progression in a COX-2-dependent manner. Clin Immunol. 134:277–288. 2010. View Article : Google Scholar : PubMed/NCBI